# Teleflex Incorporated (TFX) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $138.36, market value $5.9 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Teleflex Incorporated reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 3.1×**. Each dollar of revenue is priced at 3.1×.
- **Price / book: 2.0×**. The shares trade at 2.0× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 63.2×**. Enterprise value is 63.2× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 1.5%** (5-yr avg 2.0%). Free cash flow equals 1.5% of the market value, below its five-year average of 2.0%, so the shares are pricier on cash than usual.

## Profitability
- **Gross margin: 56.0%**. Teleflex Incorporated keeps 56.0% of revenue after the direct cost of what it sells.
- **Operating margin: -1.0%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -45.4%**. The company reported a net loss over the last twelve months.
- **Return on equity: -29.0%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -0.3%**. Return on all capital, debt included, is -0.3%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -14.9%**. Each dollar of assets produces -14.9% of profit.

## Growth
- **Revenue growth (1 yr): 17.2%** (3-yr -10.6%/yr, 5-yr -4.7%/yr). Revenue grew 17.2% over the last year, against -4.7% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -1468.2%**. Earnings per share fell 1468.2%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): -82.4%/yr**. Free cash flow has compounded at -82.4% a year over three years.

## Financial health
- **Debt to equity: 0.85**. Debt is 0.85 times equity, moderate leverage.
- **Net debt / EBITDA: 17.6×**. It would take 17.6 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Altman Z-score: 1.89**. A Z-score of 1.89 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 0.98%** ($1.36 per share, trailing). Teleflex Incorporated yields 0.98%, a modest yield more typical of a growth-oriented payer.
- **Consecutive years of increases: 26**. 26 straight years of increases (the data covers 26 years, so this may be longer): a record very few companies hold.
- **Dividend growth (5 yr): 0.0%/yr** (1-yr 0.0%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: hold** (11 analysts). 11 analysts cover Teleflex Incorporated; the consensus is hold, with an average price target of $153.55 (+11% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 8.1%** (YTD 14.0%, 3-mo 6.6%). The shares are up 8.1% over twelve months including dividends.
- **From 52-week high: -4.6%** (38.1% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 52**. An RSI of 52 is neutral.
- **Beta (1 yr): 0.80** (volatility 40%). Beta of 0.80 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=TFX · Page: https://foliofundamentals.com/stocks/tfx

Not investment advice.